SCHEMBL3786544

SCHEMBL3786544

CCCOc1cccc(Cl)c1OCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 7/20 0.58
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
CHRM2 P08172 2/20 0.49
KCNH2 Q12809 2/20 0.49
LMNA P02545 1/20 0.49
CHRM1 P11229 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
ACHE P22303 1/20 0.49
HIF1A Q16665 1/20 0.49
HTR1A P08908 3/20 0.47
ADRA1D P25100 3/20 0.47
ADRA1A P35348 3/20 0.47
ADRA1B P35368 3/20 0.47
HPGD P15428 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CSNK2A1 P68400 2/20 0.45
MAPT P10636 3/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3787026 0.91 L3MBTL1 (0.57) L3MBTL1RAB9ANPC1CHRM2KCNH2
SCHEMBL27825522 0.89 SMN1; SMN2 (0.58) L3MBTL1RAB9ANPC1LMNATSHR
SCHEMBL17826761 0.88 L3MBTL1 (0.56) L3MBTL1RAB9ANPC1CHRM2KCNH2
SCHEMBL19612363 0.87 L3MBTL1 (0.54) L3MBTL1RAB9ACHRM2KCNH2LMNA
SCHEMBL8557526 0.86 LMNA (0.62) L3MBTL1RAB9ANPC1CHRM2KCNH2
SCHEMBL15473216 0.82 ALDH1A1 (0.54) L3MBTL1RAB9ANPC1KCNH2TSHR
SCHEMBL3790085 0.82 L3MBTL1 (0.59) L3MBTL1RAB9ANPC1KCNH2LMNA
SCHEMBL8083661 0.81 RAB9A (0.49) L3MBTL1RAB9ANPC1KCNH2HPGD
SCHEMBL16572858 0.81 KDM4E (0.68) L3MBTL1RAB9ANPC1KCNH2LMNA
SCHEMBL2525928 0.80 L3MBTL1 (0.62) L3MBTL1RAB9ALMNAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 L3MBTL1 3838/4885RAB9A 1357/4885NPC1 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.